The role of fibrocytes in post-burn hypertrophic scarring

Fibrocytes: New Insights into Tissue Repair and Systemic Fibrosis

Volumn , Issue , 2007, Pages 75-103

  Wang, Jian Fei ^a   Wu, Yaujiong ^a   Medina, Abelardo ^b   Scott, Paul G ^a   Tredget, Edward E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b JACK BELL RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84967350836     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812706690_0005     Document Type: Chapter

References (72)

1. Colwell AS, Longaker MT, Lorenz HP. (2003) Fetal wound healing. Front Biosci 8: s1240-1248.
2. Tredget EE. (1994) The molecular biology of fibroproliferative disorders of the skin: Potential cytokine therapeutics. Ann Plast Surg 33: 152-154.
3. Tredget EE, Nedelec B, Scott PG, Ghahary A. (1997) Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am 77: 701-730.
4. Tredget EE. (1999) Pathophysiology and treatment of fibroproliferative disorders following thermal injury. Ann N Y Acad Sci 888: 165-182.
5. Scott PG, Ghahary A, Tredget EE. (2000) Molecular and cellular aspects of fibrosis following thermal injury. Hand Clin 16: 271-287.
6. Scott PG, Ghahary A, Chambers MM, Tredget EE. (1994) Biological basis of hypertrophic scarring. Advances in Structural Biology 3: 157-202.
7. Scott PG, Dodd CM, Tredget EE, et al. (1996) Chemical characterization and quantification of proteoglycans in human post-burn hypertrophic and mature scars. Clin Sci (Lond) 90: 417-425.
8. Linares HA, Kischer CW, Dobrkovsky M, Larson DL. (1972) The histiotypic organization of the hypertrophic scar in humans. J Invest Dermatol 59: 323-331.
9. Alexander SA, Donoff RB. (1980) The histochemistry of glycosaminoglycans within hypertrophic scars. J Surg Res 28: 171-181.
10. Scott PG, Dodd CM, Tredget EE, et al. (1995) Immunohistochemical localization of the proteoglycans decorin, biglycan and versican and transforming growth factor-beta inhumanpost-burn hypertrophic and mature scars. Histopathology 26: 423-431.
11. Scott PG, Dodd CM, Ghahary A, et al. (1998) Fibroblasts frompost-burn hypertrophic scar tissue synthesize less decorin than normal dermal fibroblasts. Clin Sci (Lond) 94: 541-547.
12. Harty M, Neff AW, King MW, Mescher AL. (2003) Regeneration or scarring: An immunologic perspective. Dev Dyn 226: 268-279.
13. Castagnoli C, Trombotto C, Ondei S, et al. (1997) Characterization of T-cell subsets infiltrating post-burn hypertrophic scar tissues. Burns 23: 565-572.
14. Castagnoli C, Stella M, Magliacani G. (2002) Role of T-lymphocytes and cytokines in post-burn hypertrophic scars. Wound Repair Regen 10: 107-108.
15. Tredget EE, Yang L, Delehanty M, et al. (2006) Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury. J Interferon Cytokine Res 26: 179-189.
16. Mosmann TR, Coffman RL. (1989) TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173.
17. Mosmann TR. (1991) Role of a new cytokine, interleukin-10, in the cross-regulation of T helper cells. Ann N Y Acad Sci 628: 337-344.
18. Peng JK, Lin JS, Kung JT, et al. (2005) The combined effect of IL-4 and IL-10 suppresses the generation of, but does not change the polarity of, type-1 T cells in Histoplasma infection. Int Immunol 17: 193-205.
19. Hoffmann KF, Cheever AW, Wynn TA. (2000) IL-10 and the dangers of immune polarization: Excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol 164: 6406-6416.
20. Wynn TA. (2004) Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 4: 583-594.
21. Caligaris-Cappio F, Bertero MT, Converso M, et al. (1995) Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity. Clin Exp Rheumatol 13: 339-343.
22. Holmes A, Abraham DJ, Chen Y, et al. (2003) Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1. J Biol Chem 278: 41728-41733.
23. Matsushima H, Hayashi S, Shimada S. (2003) Skin scratching switches immune responses from Th2 to Th1 type in epicutaneously immunized mice. J Dermatol Sci 32: 223-230.
24. Horgan AF, Mendez MV, O’Riordain DS, et al. (1994) Altered gene transcription after burn injury results in depressed T-lymphocyte activation. Ann Surg 220: 342-351; discussion 351-342.
25. O’Sullivan ST, Lederer JA, Horgan AF, et al. (1995) Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222: 482-490; discussion 490-482.
26. Desmouliere A, Badid C, Bochaton-Piallat ML, Gabbiani G. (1997) Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int J Biochem Cell Biol 29: 19-30.
27. Greenhalgh DG. (1998) The role of apoptosis in wound healing. Int J Biochem Cell Biol 30: 1019-1030.
28. Martin P. (1997) Wound healing-aiming for perfect skin regeneration. Science 276: 75-81.
29. Savill JS, Wyllie AH, Henson JE, et al. (1989) Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 83: 865-875.
30. Witko-Sarsat V, Rieu P, Descamps-Latscha B, et al. (2000) Neutrophils: Molecules, functions and pathophysiological aspects. Lab Invest 80: 617-653.
31. Wang JF, Olson ME, Reno CR, et al. (2001) The pig as a model for excisional skin wound healing: Characterization of the molecular and cellular biology, and bacteriology of the healing process. Comp Med 51: 341-348.
32. Meszaros AJ, Reichner JS, Albina JE. (1999) Macrophage phagocytosis of wound neutrophils. J Leukoc Biol 65: 35-42.
33. Deitch EA, Wheelahan TM, Rose MP, et al. (1983) Hypertrophic burn scars: Analysis of variables. J Trauma 23: 895-898.
34. Desmouliere A, Chaponnier C, Gabbiani G. (2005) Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 13: 7-12.
35. Nedelec B, Dodd CM, Scott PG, et al. (1998) Effect of interferon-alpha2b on guinea pig wound closure and the expression of cytoskeletal proteins in vivo. Wound Repair Regen 6: 202-212.
36. Nedelec B, Ghahary A, Scott PG, Tredget EE. (2000) Control of wound contraction. Basic and clinical features. Hand Clin 16: 289-302.
37. Moulin V, Larochelle S, Langlois C, et al. (2004) Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors. J Cell Physiol 198: 350-358.
38. Wassermann RJ, Polo M, Smith P, et al. (1998) Differential production of apoptosis-modulating proteins in patients with hypertrophic burn scar. J Surg Res 75: 74-80.
39. Sheikh MS, Fornace AJ, Jr. (2000) Role of p53 family members in apoptosis. J Cell Physiol 182: 171-181.
40. Linge C, Richardson J, Vigor C, et al. (2005) Hypertrophic scar cells fail to undergo a form of apoptosis specific to contractile collagen - the role of tissue transglutaminase. J Invest Dermatol 125: 72-82.
41. Leask A, Abraham DJ. (2004) TGF-beta signaling and the fibrotic response. Faseb J 18: 816-827.
42. Liu W, Wang DR, Cao YL. (2004) TGF-beta: A fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy. Curr Gene Ther 4: 123-136.
43. Longaker MT, Peled ZM, Chang J, Krummel TM. (2001) Fetal wound healing: Progress report and future directions. Surgery 130: 785-787.
44. Krummel TM, Michna BA, Thomas BL, et al. (1988) Transforming growth factor beta (TGF-beta) induces fibrosis in a fetal wound model. J Pediatr Surg 23: 647-652.
45. Ferguson MW, O’Kane S. (2004) Scar-free healing: From embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 359: 839-850.
46. Grotendorst GR. (1997) Connective tissue growth factor: Amediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 8: 171-179.
47. Frazier K, Williams S, Kothapalli D, et al. (1996) Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 107: 404-411.
48. Wang JF, Olson ME, Ball DK, et al. (2003) Recombinant connective tissue growth factor modulates porcine skin fibroblast gene expression. Wound Repair Regen 11: 220-229.
49. Brigstock DR. (2003) The CCN family: A new stimulus package. J Endocrinol 178: 169-175.
50. Igarashi A, Nashiro K, Kikuchi K, et al. (1996) Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 106: 729-733.
51. Moussad EE, Brigstock DR. (2000) Connective tissue growth factor: What’s in a name? Mol Genet Metab 71: 276-292.
52. Wang JF, Olson ME, Reno CR, et al. (2000) Molecular and cell biology of skin wound healing in a pig model. Connect Tissue Res 41: 195-211.
53. Colwell AS, Phan TT, Kong W, et al. (2005) Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation. Plast Reconstr Surg 116: 1387-1390; discussion 1391-1382.
54. Yang L, Scott PG, Giuffre J, et al. (2002) Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 82: 1183-1192.
55. Yang L, Scott PG, Dodd C, et al. (2005) Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen 13: 398-404.
56. Bucala R, Spiegel LA, Chesney J, et al. (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1: 71-81.
57. Quan TE, Cowper S, Wu SP, et al. (2004) Circulating fibrocytes: Collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 36: 598-606.
58. Mori L, Bellini A, Stacey MA, et al. (2005) Fibrocytes contribute to the myofibroblast population inwoundedskin and originate fromthe bone marrow. Exp Cell Res 304: 81-90.
59. Abe R, Donnelly SC, Peng T, et al. (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166: 7556-7562.
60. Metz CN. (2003) Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci 60: 1342-1350.
61. Hartlapp I, Abe R, Saeed RW, et al. (2001) Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. Faseb J 15: 2215-2224.
62. Chesney J, Bacher M, Bender A, Bucala R. (1997) The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci USA 94: 6307-6312.
63. Balmelli C, Ruggli N, McCullough K, Summerfield A. (2005) Fibrocytes are potent stimulators of anti-virus cytotoxic T cells. J Leukoc Biol 77: 923-933.
64. Chesney J, Metz C, Stavitsky AB, et al. (1998) Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 160: 419-425.
65. Phillips RJ, Burdick MD, Hong K, et al. (2004) Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114: 438-446.
66. Jongstra-Bilen J, Misener VL, Wang C, et al. (2000) LSP1 modulates leukocyte populations in resting and inflamed peritoneum. Blood 96: 1827-1835.
67. Jongstra-Bilen J, Janmey PA, Hartwig JH, et al. (1992) The lymphocytespecific protein LSP1 binds to F-actin and to the cytoskeleton through its COOH-terminal basic domain. J Cell Biol 118: 1443-1453.
68. Jongstra-Bilen J, Wielowieyski A, Misener V, Jongstra J. (1999) LSP1 regulates anti-IgM induced apoptosis in WEHI-231 cells and normal immature B-cells. Mol Immunol 36: 349-359.
69. Miyoshi EK, Stewart PL, Kincade PW, et al. (2001) Aberrant expression and localization of the cytoskeleton-binding pp52 (LSP1) protein in hairy cell leukemia. Leuk Res 25: 57-67.
70. Grab DJ, Salem ML, Dumler JS, Bucala R. (2004) Arole for the peripheral blood fibrocyte in leishmaniasis? Trends Parasitol 20: 12.
71. Grab DJ, Salim M, Chesney J, et al. (2002) A role for peripheral blood fibrocytes in Lyme disease? Med Hypotheses 59: 1-10.
72. Hofer MF, Jirapongsananuruk O, Trumble AE, Leung DY. (1998) Upregulation of B7.2, but not B7.1, on B cells from patients with allergic asthma. J Allergy Clin Immunol 101: 96-102.